How robust are Optimer-based affinity columns?
As part of the Biologics Europe digital conference our CTO, Dr David Bunka, was invited to present as part of Sartorius’ workshop in the ‘Protein Engineering, Protein & Antibody…
Aptamer-enhanced gene therapy delivery
Gene therapy is the future for the treatment of several, often life-threatening conditions. Several gene therapy assets are currently under trial targeting cancers, sensory organs, blood disease, and rare…
QSM Diagnostics: Spying on bacteria for rapid diagnostic applications
Novel diagnostic platforms are bringing possibilities for improved patient care and reduced healthcare costs. We spoke with Dr Edgar Goluch, the CEO and founder of QSM Diagnostics,
Fully Optimised Aptamers- Introducing Optimers
3rd October 2018 Proprietary process with validated improvement in delivery and performance OptimersTM in 12 weeks Aptamer Group is pleased to announce availability of …
Aptamer Application: Biomarker Discovery
A biomarker is a measurable indicator showing the presence or severity of a disease state. Using biomarkers to differentiate between healthy and diseased cells can enable the development of…
Aptamer Application: Flow Cytometry
Flow Cytometry Flow Cytometry is a technique used to identify biomarkers on cell surfaces and intracellular molecules. Most flow cytometers use fluorescently labelled antibodies to differentiate between cells…